In 2025, medical device manufacturers are grappling with heightened regulatory uncertainty, leading to slower reviews and communication difficulties with the FDA. This situation drives them to reassess operations for compliance and risk management, with a strong emphasis on maintaining product quality, which is vital for patient safety.
Why it Pays to Prioritize Quality Amid Regulatory Uncertainty
Related Posts
AIAG–VDA Convergence
Statistical Process Control is a critical tool used in many industries to monitor complex processes that could pose…
How to Ensure Your Robots Operate Safely
As robots gain prevalence in manufacturing, emphasizing their safe use is vital. This includes understanding safety features, challenges,…
Metrology and Quality through Education
We’re introducing a new column to share important metrology and quality news, interesting dates, and unique facts in…